How Much Is Moderna Really Worth?
The world's desperate need for vaccines and treatments to fight the COVID-19 pandemic has thrust a few companies into the limelight, including Moderna. The Massachusetts-based biotech, which specializes in using engineered messenger RNA to prevent or treat a variety of diseases, is one of the front-runners in the vaccine race. It could get emergency use authorization for its vaccine candidate from the U.S. Food and Drug Administration before the end of the year.
Moderna had already attracted investor attention before the pandemic hit after it became the biggest biotech initial public offering in history in late 2018. The company's market capitalization has soared from $6.6 billion at the beginning of the year to $28 billion now, leaving a lot of investors wondering if the stock is actually worth its current price. Superficially, a stock is worth whatever investors are willing to pay for it. But what we really care about is what investors may be willing to pay for it down the road.
Image source: Getty Images.
Source Fool.com
